RETRACTED: Mutual regulation of MDM4 and TOP2A in cancer cell proliferation
MDM4 and topoisomerase IIα (TOP2A) are overexpressed in various human cancers. MDM4 acts as an oncoprotein which promotes cancer progression by inhibiting tumor suppressor p53. As a DNA replication‐ and cell division‐regulating enzyme, TOP2A is the main target of many anticancer therapy regimens; ho...
Saved in:
| Main Authors: | Tao Liu, Hailong Zhang, Sha Yi, Lubing Gu, Muxiang Zhou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-05-01
|
| Series: | Molecular Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/1878-0261.12457 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Small-molecule MMRi36 induces apoptosis in p53-mutant lymphomas by targeting MDM2/MDM4/XIAP for degradation
by: Rati Lama, et al.
Published: (2024-12-01) -
Novel Inhibitors for MDM2-MDM4 E3 Ligase Potently Induce p53-Indepedent Apoptosis in Drug-Resistant Leukemic Cells
by: Rati Lama, et al.
Published: (2025-01-01) -
CENPN contributes to pancreatic carcinoma progression through the MDM2-mediated p53 signaling pathway
by: Ming Xu, et al.
Published: (2024-04-01) -
Tumor hypoxia evidences the differential regulation of Mdm2-p53 axis by PTEN in tumor derived vs. normal endothelial cells
by: Kinga Wilkus-Adamczyk, et al.
Published: (2024-12-01) -
Searching for novel MDM2/MDMX dual inhibitors through a drug repurposing approach
by: Keting Li, et al.
Published: (2024-12-01)